Class 2 Medicines Recall: Macleods Pharma UK Limited - Irbesartan 150mg Film-coated tablets, PL 34771/0079 (MDR 94-06/18)

Macleods Pharma UK Limited is recalling the below batches from pharmacies as a precautionary measure due to possible contamination with N‑nitrosodiethylamine (NDEA).

From:
Medicines and Healthcare products Regulatory Agency
Published
24 January 2019
Message type:
Medicines recall/notification
Medical specialty:
Anaesthetics, Cardiology, Care home staff, Cosmetic surgery and Critical care
Show 17 more
Dentistry, General practice, General surgery, Haematology and oncology, Infection prevention, Obstetrics and gynaecology, Ophthalmology, Orthopaedics, Paediatrics, Pathology, Pharmacy, Physiotherapy and occupational therapy, Radiology, Renal medicine, Theatre practitioners, Urology, and Vascular and cardiac surgery
Issued:
24 January 2018

Macleods Pharma UK Limited

Irbesartan 150mg Film-coated tablets, PL 34771/0079

  • Batch number: EIZ807A
  • Expiry date: July 2021
  • Pack size: 1 x 28
  • Date of first distribution: 21 Nov 2018

Irbesartan 300mg Film-coated tablets, PL 34771/0080

Batch number Expiry date Pack size Date of first distribution
EIA1813A July 2021 1 x 28 31 Oct 2018
EIA1811A July 2021 1 x 28 31 Oct 2018

Healthcare Professionals and wholesalers

  • Stop supplying the batches listed above immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

  • If you receive queries about this issue from patients, advise them to continue taking their medication as the health risk of discontinuing the medicine is higher than the potential risk presented by the contaminant. A treatment review is not necessary until the next routine appointment.

  • We do not anticipate any shortages of Irbesartan containing products. It is possible, however, that there may be some local supply issues, in which case patients should be advised to speak to their doctor to discuss alternative treatments.

The MHRA continues to thoroughly investigate the issue alongside the European Medicines Agency (EMA) and the European Directorate for the Quality of Medicines (EDQM). We will continue to monitor the situation in the UK and consider what actions are necessary to protect public health.

Company contacts for further information

For stock control enquiries and medical information enquiries, please contact eusafety@macleodspharma.com or telephone 01740 661110.

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS regional teams are asked to forward this to relevant clinics, general practitioners and community pharmacists.

Download document:

Drug Alert Class 2: Medicines recall - Macleods Pharma UK Limited

Updates to this page

Published 24 January 2019
Contents

Related content